Since the completion of the Human Genome Project nearly a decade ago, technological and scientific progress in the fields of genomics and personalized medicine continues to accelerate, with the next generation of human genomic research seeking to untangle the complex relationship between genes and traits and realize the promise of personalized medicine. As these fields have grown, researchers, entrepreneurs and established companies have all enjoyed increasing public and media attention – along with the attention of politicians, regulators, and judges, who are bringing a new layer of complexity to an already complicated legal and regulatory framework.
To help make sense of the resulting confusion, Robinson, Bradshaw & Hinson launched the Genomics Law Report. The Genomics Law Report focuses on the legal implications of important developments in the fields of genomics and personalized medicine — including key litigation, legislative, regulatory and policymaking activities — in order to facilitate understanding of the complicated and shifting legal landscape governing genomic and personalized medicine commerce and research.
The Genomics Law Report is designed to enable you to follow these developments as we see them, from a legal perspective, and facilitate the exchange of information and ideas within the genomics and personalized medicine communities.
To visit the Report's web site: Click Here.
Of particular interest may be a series of 36 expert guest commentaries on the most important ethical, legal or social issues involving genetic testing.
To go directly to an introduction to these commentaries: Click Here.
Note: To access the commentaries themselves, a PDF reader is required.
Thursday, December 31, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment